Showing results (1-10 of 175) with videos related to

Sort By:
Pageof 18
Best Practice & Research. Clinical Endocrinology & Metabolism|May 20, 2015
Non-neuronopathic lysosomal storage disorders: Disease spectrum and treatmentsGregory M Pastores, Derralynn A Hughes
Wiener Medizinische Wochenschrift (1946)|January 12, 2011
The pathophysiology of GD - current understanding and rationale for existing and emerging therapeutic approachesDerralynn A Hughes, Gregory M Pastores
Current Opinion in Hematology|October 31, 2012
Haematological manifestations and complications of Gaucher diseaseDerralynn A Hughes, Gregory M Pastores
Drug Design, Development and Therapy|February 28, 2020
Lysosomal Acid Lipase Deficiency: Therapeutic OptionsGregory M Pastores, Derralynn A Hughes
Diseases (Basel, Switzerland)|September 22, 2017
Lysosomal Storage Disorders and MalignancyGregory M Pastores, Derralynn A Hughes
Molecular Genetics and Metabolism|July 29, 2011
Cystatin C and NT-proBNP as prognostic biomarkers in Fabry diseaseMiguel-Ángel Torralba-Cabeza, Susana Olivera, Derralynn A Hughes, et al.
Current Opinion in Cardiology|May 21, 2016
Fabry disease: will markers of early disease enable early treatment and better outcomes?Derralynn A Hughes
Acta Paediatrica (Oslo, Norway : 1992). Supplement|May 25, 2006
The use of scoring systems in patients with haematological malignancyDerralynn A Hughes
Acta Paediatrica (Oslo, Norway : 1992)|May 28, 2008
Early therapeutic intervention in females with Fabry disease?Derralynn A Hughes
Pageof 18